Neuro-ophthalmologist with Texas Tech Physicians of El Paso Available to Speak on Diabetic Eye Disease
Texas Tech University Health Sciences Center El Paso
New research from Memorial Sloan Kettering Cancer Center (MSK)& investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.
Roswell Park experts representing various specialties will highlight innovative research and advancements in hematology and hematologic cancers at the 66th annual meeting of the American Society of Hematology (ASH), to be held December 7-10 in San Diego, California.
Investigadores de Mayo Clinic han desarrollado una estrategia de pruebas innovadoras para el mesotelioma que puede aumentar la tasa de detección del ADN del cáncer en la sangre.
Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood.
Scientists at St. Jude Children’s Research Hospital identified a link between glutamine metabolism and red blood cell maturation, showing how disruption of the process can drive disease.
Researchers from the University of Zurich and ETH Zurich have developed an advanced optical microscopy technique that enables the study of the brain’s vascular networks in unprecedented detail and on a large scale.
MSU researchers now can identify more proteins, or biomarkers, in blood plasma, including those linked to specific diseases like cancer. By identifying these biomarkers earlier, medical researchers can create better diagnostic tests and drugs that target diseases sooner, improving patient outcomes.
A new blood test developed at The Ohio State University College of Nursing – in collaboration with The Ohio State University Wexner Medical Center – is the first of its kind to potentially predict the risk for preterm birth in early pregnancy, one of the leading causes of childhood death worldwide.
Hematology researchers from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami are authors or co-authors on more than 70 posters to be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, Dec. 7-10. Links to each abstract are included in this tip sheet.
Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami will be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, Dec. 7-10.
Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab.
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society.
Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to have a significantly lower risk of hypertension, according to a new study from UTHealth Houston.
SR/RS dipeptide repeats vary in both length and position, and are phosphorylated by SR protein kinases (SRPKs). PIM-1L, the long isoform of PIM-1 kinase, the splicing of which has been implicated in acute myeloid leukemia, contains a domain that consists largely of repeating SR/RS and SH/HS dipeptides (SR/SH-rich).
Surgeons at the forefront of trauma and critical care surgery discussed at a recent news conference the urgent need to make quick access to blood more widely available to injured patients before they arrive at a hospital.
NASA crew and ground-based scientists are sending blood cells to the International Space Station on November 4 to learn why astronauts have a higher risk of blood clots.
Ivan Maillard, MD, PhD, has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).